N-morpholin-4-ylbutanamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: N-morpholin-4-ylbutanamide
• 化学式: C₈H₁₆N₂O₂
• mdl: MFCD01352982
• 分子量: 172.22
• InChiKey: VSTDMRIULHSVKP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.875
• 拓扑面积：
  41.6
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• [EN] PYRIDAZINYL AMINO DERIVATIVES AS ALK5 INHIBITORS<br/>[FR] DÉRIVÉS D'AMINO PYRIDAZINYLE UTILISÉS EN TANT QU'INHIBITEURS D'ALK5
  申请人：CHIESI FARM SPA

  公开号：WO2022013307A1

  公开（公告）日：2022-01-20

  The present invention relates to a compound of general formula (I) inhibiting the transforming growth factor-β (TGF-β) type I receptor (ALK5), methods of preparing such compounds, pharmaceutical compositions containing them and therapeutic use thereof. The compounds of the invention may be useful in the treatment of diseases or conditions associated with a dysregulation of ALK5 signaling pathway in a mammal.

  本发明涉及一种通式（I）的化合物，抑制转化生长因子-β（TGF-β）类型I受体（ALK5），制备这种化合物的方法，包含它们的药物组合物以及它们的治疗用途。本发明的化合物可能对哺乳动物中ALK5信号通路失调相关的疾病或病症的治疗有用。
• NOVEL COMPOUNDS USEFUL AS S100-INHIBITORS
  申请人：Active Biotech AB

  公开号：US20170204098A1

  公开（公告）日：2017-07-20

  A compound of formula (I) or a pharmaceutically acceptable salt thereof and a pharmaceutical composition comprising the compound. The compound is an inhibitor of interactions between S100A9 and interaction partners such as RAGE, TLR4 and EMMPRIN and as such is useful in the treatment of disorders such as cancer, autoimmune disorders, inflammatory disorders and neurodegenerative disorders.
• US9771372B2
  申请人：——

  公开号：US9771372B2

  公开（公告）日：2017-09-26